Local 12: Pregnancy and addiction
March 8, 2021
Local 12 reports on a new study that could give pregnant women with addiction a new tool to deliver a healthy baby. Christine Wilder, MD, is interviewed.
March 8, 2021
Local 12 reports on a new study that could give pregnant women with addiction a new tool to deliver a healthy baby. Christine Wilder, MD, is interviewed.
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.
October 31, 2018
A new study co-authored by a University of Cincinnati (UC) resident physician and published in the Oct. 31 online edition of the New England Journal of Medicine shows that a non-invasive radical hysterectomy may lead to shorter survival rates than open surgery in women with early-stage cervical cancer.
October 22, 2018
Researchers at the University of Cincinnati (UC) are investigating whether certain molecular markers that can be collected from simple mouthwash samples can help in identifying throat and mouth cancers.
December 4, 2020
UC researchers are seeking participants in a study for an opioid addiction treatment that could weaken withdrawal symptoms and increase the likelihood of recovery for pregnant women.
December 17, 2020
A recent study led by University of Cincinnati Cancer Center researchers shows the impact the pandemic had on lung cancer screening, which experts say could be bad for both screening programs in general and for the overall well-being of patients.
December 10, 2019
University of Cincinnati researchers published a study in the Journal of the American Academy of Child & Adolescent Psychiatry looking at side effects that impact children and adolescents being treated for anxiety disorders and obsessive-compulsive disorder (OCD).
March 20, 2020
Atsuo Sasaki's cancer research is highlighted by the international media outlet NHK World-Japan.
March 18, 2020
UC's Abhinav Sidana comments on new research that shows African American men are less likely to use a targeted biopsy option for prostate cancer.